170 related articles for article (PubMed ID: 16880955)
1. Proteomic patterns for cancer diagnosis--promise and challenges.
Whiteley GR
Mol Biosyst; 2006 Aug; 2(8):358-63. PubMed ID: 16880955
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of protein expression profile of laser capture microdissection-purified nasopharyngeal carcinoma tissue].
Peng F; Tang C; Li M; Li C; Chen A; Li F; Zhang P; Li M; Xiao Z; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):481-6. PubMed ID: 19587428
[TBL] [Abstract][Full Text] [Related]
3. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
4. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
Diamandis EP
Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
[No Abstract] [Full Text] [Related]
5. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in oncoproteomics.
Jain KK
Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
8. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
9. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
10. Opportunities for nanotechnology-based innovation in tissue proteomics.
Geho DH; Lahar N; Ferrari M; Petricoin EF; Liotta LA
Biomed Microdevices; 2004 Sep; 6(3):231-9. PubMed ID: 15377833
[TBL] [Abstract][Full Text] [Related]
11. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
12. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
13. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
[TBL] [Abstract][Full Text] [Related]
15. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
16. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
18. [Application of serum proteomics in breast cancer research].
Zhu ZM; Hu XF; Zeng R
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):561-5. PubMed ID: 18210871
[No Abstract] [Full Text] [Related]
19. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
20. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
